Skip to main content

Advertisement

ADVERTISEMENT

AP Insights, News, Videos, and More

News
04/11/2023
Tom Valentino, Digital Managing Editor
At the Rx Summit, presenters Robert DuPont, MD, Cara Poland, MD, MEd, FACP, DFASAM, and Gresha Eberly, CPRC, explained the philosophical conflicts between different approaches to addiction treatment and what providers of each can learn from...
At the Rx Summit, presenters Robert DuPont, MD, Cara Poland, MD, MEd, FACP, DFASAM, and Gresha Eberly, CPRC, explained the philosophical conflicts between different approaches to addiction treatment and what providers of each can learn from...
At the Rx Summit, presenters...
04/11/2023
Addiction Professional
News
04/11/2023
Tom Valentino, Digital Managing Editor
In an opening plenary session Monday afternoon at the Rx and Illicit Drug Summit, US Rep. Hal Rogers and FDA Commissioner Robert Califf, MD, MACC, said flipping the script on the opioid epidemic requires action on multiple fronts.
In an opening plenary session Monday afternoon at the Rx and Illicit Drug Summit, US Rep. Hal Rogers and FDA Commissioner Robert Califf, MD, MACC, said flipping the script on the opioid epidemic requires action on multiple fronts.
In an opening plenary session...
04/11/2023
Addiction Professional
Angela Huskey, PharmD, CPE
Perspectives
04/07/2023
Angela Huskey, PharmD, CPE
With recent data showing the degree to which polysubstance use is fueling the addiction crisis, currently available tools and treatments may not fully address the potent drug combinations behind today’s overdoses.
With recent data showing the degree to which polysubstance use is fueling the addiction crisis, currently available tools and treatments may not fully address the potent drug combinations behind today’s overdoses.
With recent data showing the...
04/07/2023
Addiction Professional
News
03/31/2023
Tom Valentino, Digital Managing Editor
Findings from the National Institutes of Health-supported study indicate OUD treatment with buprenorphine can be safely started in an emergency department without triggering withdrawal, even among individuals who use stronger opioids.
Findings from the National Institutes of Health-supported study indicate OUD treatment with buprenorphine can be safely started in an emergency department without triggering withdrawal, even among individuals who use stronger opioids.
Findings from the National...
03/31/2023
Addiction Professional
News
03/29/2023
Tom Valentino, Digital Managing Editor
The US Food and Drug Administration (FDA) on Wednesday announced that it has approved Narcan, 4 milligram naloxone hydrochloride nasal spray for over-the-counter, nonprescription use. Narcan becomes the first naloxone product approved for use...
The US Food and Drug Administration (FDA) on Wednesday announced that it has approved Narcan, 4 milligram naloxone hydrochloride nasal spray for over-the-counter, nonprescription use. Narcan becomes the first naloxone product approved for use...
The US Food and Drug...
03/29/2023
Addiction Professional
News
03/28/2023
Tom Valentino, Digital Managing Editor
More than 7% of urine samples collected in a cross-sectional study showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence.
More than 7% of urine samples collected in a cross-sectional study showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence.
More than 7% of urine samples...
03/28/2023
Addiction Professional
News
03/24/2023
Tom Valentino, Digital Managing Editor
Researchers at Washington University in St. Louis, Missouri, have identified genes commonly inherited across addiction disorders, potentially paving the way for new treatment targets across multiple substance use disorders, including...
Researchers at Washington University in St. Louis, Missouri, have identified genes commonly inherited across addiction disorders, potentially paving the way for new treatment targets across multiple substance use disorders, including...
Researchers at Washington...
03/24/2023
Addiction Professional
News
03/22/2023
Tom Valentino, Digital Managing Editor
The US Drug Enforcement Administration said in an alert that it has seen a sharp increase in the trafficking of fentanyl mixed with xylazine, having made seizures in 48 states.
The US Drug Enforcement Administration said in an alert that it has seen a sharp increase in the trafficking of fentanyl mixed with xylazine, having made seizures in 48 states.
The US Drug Enforcement...
03/22/2023
Addiction Professional
News
03/21/2023
Tom Valentino, Digital Managing Editor
Pairing contingency management and bupropion, an antidepressant medication that is also used for smoking cessation, could be a treatment option for curbing cocaine use by patients who are in treatment for opioid use disorder, according to...
Pairing contingency management and bupropion, an antidepressant medication that is also used for smoking cessation, could be a treatment option for curbing cocaine use by patients who are in treatment for opioid use disorder, according to...
Pairing contingency management...
03/21/2023
Addiction Professional
Nate Pelletier
Perspectives
03/16/2023
Nate Pelletier
The transition to value-based care (VBC) in the substance use disorder (SUD) industry is a good sign, but it can be challenging for some providers.
The transition to value-based care (VBC) in the substance use disorder (SUD) industry is a good sign, but it can be challenging for some providers.
The transition to value-based...
03/16/2023
Behavioral Healthcare Executive

Advertisement

Advertisement